Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-26-336774
Filing Date
2026-08-06
Accepted
2026-08-06 07:45:40
Documents
65
Period of Report
2026-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q clym-20260630.htm   iXBRL 10-Q 2694532
2 EX-10.1 clym-ex10_1.htm EX-10.1 22543
3 EX-31.1 clym-ex31_1.htm EX-31.1 18001
4 EX-31.2 clym-ex31_2.htm EX-31.2 17385
5 EX-32.1 clym-ex32_1.htm EX-32.1 11043
6 EX-32.2 clym-ex32_2.htm EX-32.2 10423
7 GRAPHIC img21820648_0.jpg GRAPHIC 179068
  Complete submission text file 0001193125-26-336774.txt   10709313

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT clym-20260630.xsd EX-101.SCH 1629474
69 EXTRACTED XBRL INSTANCE DOCUMENT clym-20260630_htm.xml XML 1690063
Mailing Address 20 WILLIAM STREET SUITE 145 WELLESLEY HILLS MA 02481
Business Address 20 WILLIAM STREET SUITE 145 WELLESLEY HILLS MA 02481 1-866-857-2596
Climb Bio, Inc. (Filer) CIK: 0001768446 (see all company filings)

EIN.: 832273741 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40708 | Film No.: 261246068
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)